An updated mini review of Vitamin D and obesity: Adipogenesis and inflammation state

Open Access Macedonian Journal of Medical Sciences

Volumn 4, Issue 3, 2016, Pages 526-532

  Hamid Mehmood, Zujaja Tul Noor ^a   Papandreou, Dimitrios ^a  

^a ZAYED UNIVERSITY   (United Arab Emirates)

Author keywords

1,25(OH)2D3; Adipocyte; Inflammation; Obesity

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CALCIUM SENSING RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PARATHYROID HORMONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; VITAMIN D;

ADIPOGENESIS; BIBLIOGRAPHIC DATABASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL (TOPIC); ENDOPLASMIC RETICULUM STRESS; EPIGENETICS; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; META ANALYSIS (TOPIC); NONHUMAN; OBESITY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); UNFOLDED PROTEIN RESPONSE;

EID: 84988985775     PISSN: None     EISSN: 18579655     Source Type: Journal    
DOI: 10.3889/oamjms.2016.103     Document Type: Review

References (61)

1. Kohlmeier M. Introduction. In: Kohlmeier M, Ed. Nutrient Metabolism: Structures, Functions, and Genes. 2nd ed. Academic Press, 2015: Pp. xxvii. http://dx.doi.org/10.1016/B978-0-12-387784-0.00016-X
2. Holick MF. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med 2008; 29(6): 361-8. http://dx.doi.org/10.1016/j.mam.2008.08.008
3. National Institute of Health 2014. Vitamin D Fact Sheet for Health Professionals. From: https://ods.od.nih.gov/pdf/factsheets/VitaminD-HealthProfessional.pdf. Accessed: January 2016.
4. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academic Press (US), 2011.
5. Ryan JW, Anderson PH & Morris HA. Pleiotropic Activities of Vitamin D Receptors - Adequate Activation for Multiple Health Outcomes. Clin Biochem Rev. 2015; 36(2): 53-61.
6. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011; 96(1): 53-8. http://dx.doi.org/10.1210/jc.2010-2704
7. Hollick MF. Vitamin D Deficiency. N Engl J Med 2007;357:266-281. http://dx.doi.org/10.1056/NEJMra070553
8. Institute for Health Metrics and Evaluation. The State of US Health: Innovations, Insights, and Recommendations from the Global Burden of Disease Study. Seattle, WA: Institute for Health Metrics and Evaluation, 2013.
9. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384(9945):766-781. http://dx.doi.org/10.1016/S0140-6736(14)60460-8
10. Vanlint S. Vitamin D and obesity. Nutrients. 2013; 5(3): 949-56. http://dx.doi.org/10.3390/nu5030949
11. Hawkins R. Total 25-OH vitamin D concentrations in Chinese, Malays and Indians. Ann Lab Med. 2013; 33(2): 156-8. http://dx.doi.org/10.3343/alm.2013.33.2.156
12. Koszowska A, Nowak J, Dittfeld A, Brończyk-Puzoń A, Kulpok A, Zubelewicz-Szkodzińska B. Obesity, adipose tissue function and the role of vitamin D. Cent Eur J Immunol. 2014; 2:260-264. http://dx.doi.org/10.5114/ceji.2014.43732
13. Pourshahidi L. Vitamin D and obesity: current perspectives and future directions. Proc Nutr Soc. 2014; 74(02):115-124. http://dx.doi.org/10.1017/S0029665114001578
14. Pereira-Santos M, Costa P, Assis A, Santos C, Santos D. Obesity and vitamin D deficiency: a systematic review and metaanalysis. Obes Rev. 2015; 16(4):341-349. http://dx.doi.org/10.1111/obr.12239
15. Zuk A, Fitzpatrick T, Rosella L. Effect of Vitamin D3 Supplementation on Inflammatory Markers and Glycemic Measures among Overweight or Obese Adults: A Systematic Review of Randomized Controlled Trials. PLoS One. 2016; 11(4):e0154215. http://dx.doi.org/10.1371/journal.pone.0154215
16. Tripathi YB, Pandey V. Obesity and endoplasmic reticulum (ER) stresses. Front Immunol. 2012; 3240. http://dx.doi.org/10.3389/fimmu.2012.00240
17. Chang YC, Hee SW, Hsieh ML, Jeng YM & Chuang LM. The Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for Treatment. Anal Cell Pathol (Amst). 2015; 2015:972891. http://dx.doi.org/10.1155/2015/972891
18. Jonas MI, Kurylowicz A, Bartoszewicz Z, Lisik W, Jonas M, Wierzbicki Z et al. Interleukins 6 and 15 Levels Are Higher in Subcutaneous Adipose Tissue, but Obesity Is Associated with Their Increased Content in Visceral Fat Depots. Int J Mol Sci. 2015; 16(10): 25817-30. http://dx.doi.org/10.3390/ijms161025817
19. Spoto B, Di Betta E, Mattace-Raso F, Sijbrands E, Vilardi A, Parlongo RM et al. Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity. Nutr Metab Cardiovasc Dis. 2014; 24(10): 1137-43. http://dx.doi.org/10.1016/j.numecd.2014.04.017
20. Gangloff A, Bergeron J, Pelletier-Beaumont E, Nazare JA, Smith J, Borel AL et al. Effect of adipose tissue volume loss on circulating 25-hydroxyvitamin D levels: results from a 1-year lifestyle intervention in viscerally obese men. Int J Obes (Lond). 2015; 39(11): 1638-43. http://dx.doi.org/10.1038/ijo.2015.118
21. Ceglia L, Nelson J, Ware J, Alysandratos KD, Bray GA, Garganta C et al. Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program. Eur J Nutr. 2015 [Epub ahead of print]. http://dx.doi.org/10.1007/s00394-015-1066-z
22. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 2013; 10(2): e1001383. http://dx.doi.org/10.1371/journal.pmed.1001383
23. Hannemann A, Thuesen BH, Friedrich N, Volzke H, Steveling A, Ittermann T et al. Adiposity measures and vitamin D concentrations in Northeast Germany and Denmark. Nutr Metab (Lond). 2015; 12(24). http://dx.doi.org/10.1186/s12986-015-0019-0
24. Kremer R, Campbell PP, Reinhardt T & Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab. 2009; 94(1): 67-73. http://dx.doi.org/10.1210/jc.2008-1575
25. Yao Y, Zhu L, He L, Duan Y, Liang W, Nie Z et al. A metaanalysis of the relationship between vitamin D deficiency and obesity. Int J Clin Exp Med. 2015; 8(9): 14977-84.
26. Ghavamzadeh S, Mobasseri M, Mahdavi R. The Effect of Vitamin D Supplementation on Adiposity, Blood Glycated Hemoglobin, Serum Leptin and Tumor Necrosis Factor-α in Type 2 Diabetic Patients. Int J Prev Med. 2014; 5(9):1091-8.
27. Maggi S, Siviero P, Brocco E, Albertin M, Romanato G, Crepaldi G. Vitamin D deficiency, serum leptin and osteoprotegerin levels in older diabetic patients: an input to new research avenues. Acta Diabetol. 2013; 51(3):461-469. http://dx.doi.org/10.1007/s00592-013-0540-4
28. Dinca M, Serban M, Sahebkar A, Mikhailidis D, Toth P, Martin S et al. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2016; 107:360-371. http://dx.doi.org/10.1016/j.phrs.2016.03.035
29. Gallagher JC, Sai A, Templin I, Thomas & Smith L. Dose Response to Vitamin D Supplementation in Postmenopausal WomenA Randomized Trial. Ann Intern Med. 2012; 156(6): 425-37. http://dx.doi.org/10.7326/0003-4819-156-6-201203200-00005
30. Wamberg L, Christiansen T, Paulsen SK, Fisker S, Rask P, Rejnmark L et al. Expression of vitamin D-metabolizing enzymes in human adipose tissue -- the effect of obesity and diet-induced weight loss. Int J Obes (Lond). 2013; 37(5): 651-7. http://dx.doi.org/10.1038/ijo.2012.112
31. He Y, Perry B, Bi M, Sun H, Zhao T, Li Y et al. Allosteric regulation of the calcium-sensing receptor in obese individuals. Int J Mol Med. 2013; 32(2): 511-8.
32. Cifuentes M, Fuentes C, Tobar N, Acevedo I, Villalobos E, Hugo E et al. Calcium sensing receptor activation elevates proinflammatory factor expression in human adipose cells and adipose tissue. Mol Cell Endocrinol. 2012; 361(1-2): 24-30. http://dx.doi.org/10.1016/j.mce.2012.03.006
33. He YH, Song Y, Liao XL, Wang L, Li G, Alima et al. The calcium-sensing receptor affects fat accumulation via effects on antilipolytic pathways in adipose tissue of rats fed low-calcium diets. J Nutr. 2011; 141(11): 1938-46. http://dx.doi.org/10.3945/jn.111.141762
34. Patel N, Pasupathy D & Poston L. Determining the consequences of maternal obesity on offspring health. Exp Physiol. 2015; 100(12); 1421-8. http://dx.doi.org/10.1113/EP085132
35. Penfold NC & Ozanne SE. Developmental programming by maternal obesity in 2015: Outcomes, mechanisms, and potential interventions. Horm Behav. 2015; 76; 143-52. http://dx.doi.org/10.1016/j.yhbeh.2015.06.015
36. Morales E, Rodriguez A, Valvi D, Iniguez C, Esplugues A, Vioque J et al. Deficit of vitamin D in pregnancy and growth and overweight in the offspring. Int J Obes (Lond). 2015; 39(1): 61-8. http://dx.doi.org/10.1038/ijo.2014.165
37. Hossein-nezhad A, Holick MF. Vitamin D for Health: A Global Perspective. Mayo Clin Proc. 2013; 88(7): 720-55. http://dx.doi.org/10.1016/j.mayocp.2013.05.011
38. Murthi P, Yong H, Ngyuen T, Ellery S, Singh H, Rahman R et al. Role of the Placental Vitamin D Receptor in Modulating FetoPlacental Growth in Fetal Growth Restriction and Preeclampsia-Affected Pregnancies. Front Physiol. 2016; 7:43. http://dx.doi.org/10.3389/fphys.2016.00043
39. Hart P, Lucas R, Walsh J, Zosky G, Whitehouse A, Zhu K et al. Vitamin D in Fetal Development: Findings From a Birth Cohort Study. Pediatrics. 2014; 135(1):e167-e173. http://dx.doi.org/10.1542/peds.2014-1860
40. Cediel G, Corvalán C, Aguirre C, de Roma-a D, Uauy R. Serum 25-Hydroxyvitamin D associated with indicators of body fat and insulin resistance in prepubertal chilean children. Int J Obes (Lond). 2015; 40(1):147-152. http://dx.doi.org/10.1038/ijo.2015.148
41. Cediel G, Corvalan C, Lopez de Romana D, Mericq V, Uauy R. Prepubertal Adiposity, Vitamin D Status, and Insulin Resistance. Pediatrics. 2016;138(1):e20160076-e20160076. http://dx.doi.org/10.1542/peds.2016-0076
42. Alkharfy KM, Ahmed M, Yakout SM & Al-Daghri NM. Effects of calcitriol on structural changes of kidney in C57BL/6J mouse model. Int J Clin Exp Med. 2015; 8(8): 12390-6.
43. Oliai AS, van Dijk SC, Ham AC, Brouwer-Brolsma EM, Enneman AW, Sohl E et al. BMI and Body Fat Mass Is Inversely Associated with Vitamin D Levels in Older Individuals. J Nutr Health Aging. 2015; 19(10): 980-5. http://dx.doi.org/10.1007/s12603-015-0657-y
44. Duggan C, de Dieu Tapsoba J, Mason C, Imayama I, Korde L, Wang CY et al. Effect of Vitamin D3 Supplementation in Combination with Weight Loss on Inflammatory Biomarkers in Postmenopausal Women: A Randomized Controlled Trial. Cancer Prev Res (Phila). 2015; 8(7): 628-35. http://dx.doi.org/10.1158/1940-6207.CAPR-14-0449
45. Rodriguez-Rodriguez E, Aparicio A, Andres P & Ortega RM. Moderate vitamin D deficiency and inflammation related markers in overweight/obese schoolchildren. Int J Vitam Nutr Res. 2014; 84(1-2): 98-107. http://dx.doi.org/10.1024/0300-9831/a000197
46. Ding C, Wilding JP & Bing C. 1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFkappaB and MAPK signalling and chemokine release in human adipocytes. PLoS One. 2013; 8(4): e61707. http://dx.doi.org/10.1371/journal.pone.0061707
47. Jamka M, Wozniewicz M, Jeszka J, Mardas M, Bogdanski P & Stelmach-Mardas M. The effect of vitamin D supplementation on insulin and glucose metabolism in overweight and obese individuals: systematic review with meta-analysis. Sci Rep. 2015; 516142. http://dx.doi.org/10.1038/srep16142
48. Chandler PD, Wang L, Zhang X, Sesso HD, Moorthy MV, Obi O et al. Effect of vitamin D supplementation alone or with calcium on adiposity measures: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2015; 73(9): 577-93. http://dx.doi.org/10.1093/nutrit/nuv012
49. Shah S, Wilson DM & Bachrach LK. Large Doses of Vitamin D Fail to Increase 25-Hydroxyvitamin D Levels or to Alter Cardiovascular Risk Factors in Obese Adolescents: A Pilot Study. J Adolesc Health. 2015; 57(1): 19-23. http://dx.doi.org/10.1016/j.jadohealth.2015.02.006
50. Gallagher JC, Peacock M, Yalamanchili V & Smith LM. Effects of vitamin D supplementation in older African American women. J Clin Endocrinol Metab. 2013; 98(3): 1137-46. http://dx.doi.org/10.1210/jc.2012-3106
51. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2010; 59: 242–248. http://dx.doi.org/10.2337/db09-1011
52. Seo JiA, Eun CR, Cho H, Lee SK, You HG, Kim SG et al. Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults. PLoS One. 2013; 9: 8(10):e75197.
53. Guasch A, Bullo M, Rabassa A, Bonada A, Del Castillo D, Sabench F et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a crosssectional study. Cardiovasc Diabetol. 2012; 11:149. http://dx.doi.org/10.1186/1475-2840-11-149
54. Rusconi RE, De Cosmi V, Gianluca G, Giavoli C & Agostoni C. Vitamin D insufficiency in obese children and relation with lipid profile. Int J Food Sci Nutr. 2015; 66(2): 132-4. http://dx.doi.org/10.3109/09637486.2014.959902
55. Javed A, Vella A, Balagopal PB, Fischer PR, Weaver AL, Piccinini F et al. Cholecalciferol supplementation does not influence beta-cell function and insulin action in obese adolescents: a prospective double-blind randomized trial. J Nutr. 2015; 145(2): 284-90. http://dx.doi.org/10.3945/jn.114.202010
56. Riek AE, Oh J, Darwech I, Moynihan CE, Bruchas RR & Bernal-Mizrachi C. 25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes. J Steroid Biochem Mol Biol. 2014; 144 (Pt A):172-9.
57. Riek AE, Oh J, Sprague JE, Timpson A, de las Fuentes L, Bernal-Mizrachi L et al. Vitamin D suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte/macrophage phenotype in type 2 diabetic patients. J Biol Chem. 2012; 287(46): 38482-94. http://dx.doi.org/10.1074/jbc.M112.386912
58. Ibero-Baraibar I, Navas-Carretero S, Abete I, Martinez JA & Zulet MA. Increases in plasma 25(OH)D levels are related to improvements in body composition and blood pressure in middleaged subjects after a weight loss intervention: Longitudinal study. Clin Nutr. 2015; 34(5): 1010-7. http://dx.doi.org/10.1016/j.clnu.2014.11.004
59. Fornari R, Francomano D, Greco EA, Marocco C, Lubrano C, Wannenes F et al. Lean mass in obese adult subjects correlates with higher levels of vitamin D, insulin sensitivity and lower inflammation. J Endocrinol Invest. 2015; 38(3): 367-72. http://dx.doi.org/10.1007/s40618-014-0189-z
60. AL-Suhaimi EA, Shehzad A. Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res. 2013;18(12):1–13. http://dx.doi.org/10.1186/2047-783x-18-12
61. Sabry D, Al-Ghussein M, Hamdy G, Abul-Fotouh A, Motawi T, El Kazaz A et al. Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients. Clin Risk Manag. 2015; 11: 279–288. http://dx.doi.org/10.2147/TCRM.S66763